Mid-Day Gainers From December 30: Neuroderm, Neonode And More

By: via Benzinga
Neuroderm Ltd (NASDAQ: NDRM) +90% - The company announced favorable Phase IIa Parkinson’s treatment study results. China ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.